Live from the NIH registry
Studies recruiting near Austin right now
Top 25 of 757 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Dell Seton Medical Center /ID# 247016 — Austin, Texas (2.4 mi)
· Sponsor: AbbVie
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Texas Oncology-Austin Central — Austin, Texas (2.4 mi)
· Sponsor: Kartos Therapeutics, Inc.
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Texas Oncology — Austin, Texas (2.4 mi)
· Sponsor: Dosentrx Ltd.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Texas Oncology- Austin — Austin, Texas (2.4 mi)
· Sponsor: SCRI Development Innovations, LLC
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Urology Austin — Lakeway, Texas (14.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Austin, Texas (2.4 mi)
· Sponsor: Sameek Roychowdhury
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
St. David's South Austin Medical Center — Austin, Texas (2.4 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
The University of Texas at Austin — Austin, Texas (2.4 mi)
· Sponsor: Janssen Research & Development, LLC
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Texas Diabetes & Endocrinology — Austin, Texas (2.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Texas Oncology - Austin — Austin, Texas (2.4 mi)
· Sponsor: Immuneering Corporation
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Texas Cardiac Arrhythmia Foundation — Austin, Texas (2.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
PAS-004 in Patients With Advanced Solid Tumors
RAS Mutation, NF1 Mutation
Phase 1
Interventional 48 participants sought
NEXT Oncology — Austin, Texas (2.4 mi)
· Sponsor: Pasithea Therapeutics Corp.
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Dell Children's Blood and Cancer Center — Austin, Texas (2.4 mi)
· Sponsor: Giselle Sholler
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Focal Onset Seizure, Primary Generalized Epilepsy
Phase 2
Interventional 50 participants sought
Praxis Research Site — Round Rock, Texas (15.0 mi)
· Sponsor: Praxis Precision Medicines
Co-Creating Active Middle School Communities to Increase Student Physical Activity
Physical Activity
N/A
Interventional 450 participants sought
The University of Texas Health Science Center at Houston — Austin, Texas (2.4 mi)
· Sponsor: Deanna Hoelscher
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Texas Oncology - Central/South Texas — Austin, Texas (2.4 mi)
· Sponsor: Pfizer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Austin, Texas (2.4 mi)
· Sponsor: Daiichi Sankyo
Remotely-supervised Neuromodulation in PPA
Primary Progressive Aphasia(PPA), Progressive Aphasia
N/A
Interventional 80 participants sought
University of Texas — Austin, Texas (2.4 mi)
· Sponsor: Maya Henry
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Austin Retina Associates — Austin, Texas (2.4 mi)
· Sponsor: Genentech, Inc.
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Dell Children's Blood and Cancer Center — Austin, Texas (2.4 mi)
· Sponsor: Giselle Sholler
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10015 Austin, TX Investigational Site — Austin, Texas (2.4 mi)
· Sponsor: Colorado Prevention Center
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Midtown Urology Associates — Austin, Texas (2.4 mi)
· Sponsor: Urotronic Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577 — Austin, Texas (2.4 mi)
· Sponsor: AbbVie
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
Texas Oncology - Austin Central /ID# 275046 — Austin, Texas (2.4 mi)
· Sponsor: AbbVie
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Solace Clinical Research- Site Number : 8400087 — Austin, Texas (2.4 mi)
· Sponsor: Sanofi